top of page

Comprehensive ADHD Evaluations That Go Beyond the Diagnosis

A thorough ADHD evaluation is the foundation for understanding your attention, focus, and behavior patterns—and how they impact your daily life. At Serenity Psychiatry and Wellness, we take a comprehensive, whole-person approach to ADHD assessment, because effective treatment begins with clarity and accuracy.

ADHD symptoms can look different for everyone. A comprehensive evaluation looks beyond surface symptoms to understand how ADHD affects your mood, relationships, work, and overall well-being. It often includes clinical interviews, standardized rating scales, medical and family history, and screening for co-occurring conditions like anxiety, depression, or sleep issues.

This deeper understanding allows us to create a personalized treatment plan that may include behavioral strategies, medication management, and lifestyle adjustments. By evaluating the full picture—not just the symptoms—we can better address your unique strengths and challenges and support you in reaching your full potential. 

​

Comprehensive evaluation is not just about confirming a diagnosis—it is about understanding you and guiding treatment that truly fits your life.

​​Our protocol consists of a THREE part comprehensive evaluation:

​

  1. One hour consultation with one of our Board Certified PMHNP providers

  2. Completion of questionnaires and testing with Qb Check and Creyos

  3. Reviewing results to develop a treatment plan collaboratively.

​
QbCheck is web-based, FDA-cleared, TGA-registered, and backed by extensive research. Both QB check and Creyos consist of ADHD tests completed in office that enable healthcare professionals to objectively measure core ADHD symptoms: inattention, activity, and impulsivity.

Creyos Logo
QbCheck Logo

It is important to note that as of 2026, New Jersey law requires in-person visits for patients prescribed stimulant medications. Under Executive Order 415, clinicians must conduct an initial in-person evaluation before prescribing any Schedule II controlled substance, followed by in-person follow-up visits every three months for ongoing prescriptions. This updated requirement helps ensure stimulant medications are prescribed and monitored safely and responsibly for all New Jersey patients. 

bottom of page